The HPV test in cervical screening: A brave new world?

Cytopathology

Volumn 16, Issue 1, 2005, Pages 3-6

  Desai, M S ^a   Cubie, Heather A ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC VALUE; EDITORIAL; GENOTYPE; HUMAN; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS INFECTION; WART VIRUS;

CYTODIAGNOSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 14344258386     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2005.00237.x     Document Type: Editorial

References (27)

1. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap. Test accuracy. Am J Epidemiol 1995;141:680-9.
2. Department of Health and Human Services, Agency for Health Care Policy Research. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment 5, AHCPR publication 99-E010. Bethesda, MD: Department of Health and Human Services, Agency for Health Care Policy Research; 1999.
3. Stoler MH, Schiffman MH. Interobserver variability of cervical cytologic and histologic interpretations: realistic estimates form the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-5 [PubMed Citation].
4. Walboomers JM, Jacobs MV, Manos M et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. Park TW, Richart RM, Sun XW et al. Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J. Natl Cancer Inst 1996;88:355-8.
6. Jacobs MV, Zielinski D, Meijer CJ et al. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 2000;82:1421-6 [PubMed Citation].
7. Rozendaal L, Walboomers JM, van der Linden JC et al. PCR-based high-risk HPV test in cervical cancer screening gives objective assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996;68:766-9.
8. Arbyn M, Burtinx F, Ranst MV, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virological versus cytology triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial Neoplasia. J Natl Cancer Inst 2004;96:280-93.
9. ALTS Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
10. Cuzick J, Szarewski A, Cubic H et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-6.
11. Bulkmans NWJ, Rozendaal L, Snijders PJ et al. POBA-SCAM, a population- based randomised controlled trial for implementation of high-risk HPV testing in cervical screening; Design, methods and baseline data of 44,102 women. Int J Cancer 2003;110:94-101.
12. Artistic Trial: A Randomised Trial of HPV Testing in Primary Cervical Screening. http://www.cancerscreening.nhs.uk/ cervical/hpv.html (last accessed 24 January 2005)
13. Lorincz AT, Anthony J. Advances in HPV detection by hybrid capture. Papillomavirus Rep 2001;12:145-54.
14. Kornegay JR, Roger M, Davies PO et al. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol 2003;41:1080-6.
15. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
16. Cuzick J, Beverley E, Ho L et al. HPV testing in primary screening of older women. Br J Cancer 1999;81:554-8.
17. Schiffman M, Herrero R, Hildensheim A et al. HPV DNA testing in cervical cancer screening. JAMA 2000;283:87-93.
18. Wright TC Jr, Schiffman M, Solomon D et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.
19. Waller J, McCaffery K, Wardle J. Beliefs about the risk factors for cervical cancer in a British population sample. Preventative Med 2004;38:745-53.
20. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 2004;328:1293-8.
21. Goldie SJ, Freedberg KA, Weinstein MC, Wright TC, Kuntz KM. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med 2001;111:140-9.
22. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158-71.
23. van Ballegooijen M, van den Akker-van Marie ME, Warmerdam PG, Meijer CJ, Walboomers JM, Habbema JD. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-) effectiveness. Br J Cancer 1997;76:651-7.
24. Cuzick J, Sasieni P. Estimates of the cost of impact of introducing human papillomavirus testing into a cervical screening programme. In: New Developments in Cervical Cancer Screening and Prevention. Franco EL, Monsonego J (eds). Oxford: Blackwell; 1997: p. 364-372.
25. Moss SM, Gray A, Marteau T et al. Evaluation of HPV/ LBC Cervical Screening Pilot Studies. Summary of Reports to the Department of Health, October 2004, UK. (available at http://www.cancerscreening.nhs.uk/ cervical/ evaluation_hpv.pdf).
26. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl. 8):S4-66.
27. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings. JAMA 2001;285:3107-15.